newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Provides Interim Sales Information

TORRANCE, Calif., July 22, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC:EMMA), a leader in sickle cell disease treatment, announced today preliminary sales results for the six months ended June 30, 2021.